Gary D. Gentzkow
Directeur Technique/Scientifique/R&D chez Theregen, Inc.
Profil
Gary D.
Gentzkow is currently the Chief Medical Officer at Theregen, Inc. and Excaliard Pharmaceuticals, Inc. He previously worked as the Medical Director at Advanced Tissue Sciences, Inc., Chief Medical Officer at TGI Holdings, Inc., and Principal at Smith + Nephew, Inc. Gentzkow received his undergraduate degree from Harvard University and his doctorate from Oregon Health & Science University.
Postes actifs de Gary D. Gentzkow
Sociétés | Poste | Début |
---|---|---|
Theregen, Inc.
Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | - |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | 06/08/2009 |
Anciens postes connus de Gary D. Gentzkow
Sociétés | Poste | Fin |
---|---|---|
Smith + Nephew, Inc.
Smith + Nephew, Inc. Medical SpecialtiesHealth Technology Smith & Nephew, Inc. develops and markets medical devices. Its products include television cameras and monitors, endoscopes, arthroscopes, orthopedic hand owered instruments, fiber optic illumination systems, laparoscopes, and surgical instruments. The company was founded on November 27, 1975 and is headquartered in Memphis, TN. | Corporate Officer/Principal | - |
Advanced Tissue Sciences, Inc. | Directeur Technique/Scientifique/R&D | - |
TGI Holdings, Inc. /Hawaii/
TGI Holdings, Inc. /Hawaii/ Medical SpecialtiesHealth Technology TGI Holdings, Inc. develops tissue engineering and cell therapy solutions. The company was founded by Anton C. Krucky, Thomas F. Cannon, and William P. Wiesmann in 2001 and is headquartered in Honolulu, HI. | Directeur Technique/Scientifique/R&D | - |
Formation de Gary D. Gentzkow
Harvard University | Undergraduate Degree |
Oregon Health & Science University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
TGI Holdings, Inc. /Hawaii/
TGI Holdings, Inc. /Hawaii/ Medical SpecialtiesHealth Technology TGI Holdings, Inc. develops tissue engineering and cell therapy solutions. The company was founded by Anton C. Krucky, Thomas F. Cannon, and William P. Wiesmann in 2001 and is headquartered in Honolulu, HI. | Health Technology |
Theregen, Inc.
Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | Commercial Services |
Smith + Nephew, Inc.
Smith + Nephew, Inc. Medical SpecialtiesHealth Technology Smith & Nephew, Inc. develops and markets medical devices. Its products include television cameras and monitors, endoscopes, arthroscopes, orthopedic hand owered instruments, fiber optic illumination systems, laparoscopes, and surgical instruments. The company was founded on November 27, 1975 and is headquartered in Memphis, TN. | Health Technology |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Health Technology |
Advanced Tissue Sciences, Inc. | Commercial Services |